American Heart Association
| Mechanism | Who Should Apply | Funding | Purpose | Deadline | Website |
|---|---|---|---|---|---|
| Institutional Undergraduate Award | See eligible institutions | $165k / 3 yrs | Undergraduate research training | Sept. 9, 2026 | 2027 Undergraduate Student Training |
| AIREA | See eligible institutions | $200k / 2 yrs | Research enhancement | Sept. 10, 2026 | 2027 Institutional Research Enhancement Award |
| Career Development Award | Early-stage faculty | $231k / 3 yrs | Launch independent career | Dec. 1, 2026 | 2027 Career Development Award |
American Cancer Society (ACS)
| Mechanism | Who Should Apply | Funding | Purpose | Deadline | Website |
|---|---|---|---|---|---|
| Mission Boost Grant | Independent investigators | Stage I: $135K/yr; Stage II: $545K | Accelerate clinical translation | June 1 & Dec. 1 | Mission Boost Grants (MBG) |
| Postdoctoral Fellowship | ≤3 years postdoctoral training | $66K-$70K + allowances | Postdoctoral training | June 1 & Dec. 1 | Postdoctoral Fellowships |
Department of Defense – Congressionally Directed Medical Research Programs (CDMRP)
Selected Research Programs: Prostate Cancer Research Program (PCRP)
| Mechanism | Who Should Apply | Funding | Purpose | Deadline |
|---|---|---|---|---|
| Early Investigator Research Award (EIRA) | Early-career investigators beginning independent research careers | Up to $630,000 total costs over 3 years | Mentored career development to establish an independent, hypothesis-driven prostate cancer research program. | LOI: Aug. 12, 2026 Full Application: Sept. 2, 2026 |
| Idea Development Award (IDA) | Independent investigators proposing highly innovative research; separate funding levels available for New Investigator and Established Investigator options | Up to $1.7M (New Investigator) or $2.1M (Established Investigator) total costs over 3 years (for EI) or 4 years (for NI) | Supports high-impact, potentially paradigm-shifting prostate cancer research supported by a strong scientific rationale. | LOI: Aug. 12, 2026 Full Application: Sept. 2, 2026 |
| Physician Research Award (PRA) | Physicians (MD/DO or equivalent) pursuing research careers in prostate cancer under mentorship of an experienced investigator | Up to $1.1M total costs over 4 years | Provides protected research time and mentored training to develop physician-scientists with independent prostate cancer research careers. | LOI: Aug. 12, 2026 Full Application: Sept. 2, 2026 |
Peer Reviewed Medical Research Program (PRMRP)
| Mechanism | Who Should Apply | Funding | Purpose | Deadline |
|---|---|---|---|---|
| Clinical Trial Award (CTA) | Investigators with a well-developed clinical intervention ready for human testing | Up to $15M total costs (up to $8M guaranteed from FY26 funds; additional funding contingent on future appropriations) | Supports rapid implementation of Phase 0–III clinical trials evaluating promising interventions. | Pre-Proposal: July 23, 2026 Application: Sept. 22, 2026 |
| Platform Clinical Translation Award (PCTA) | Multidisciplinary teams with advanced platform technologies applicable to multiple diseases | Up to $15M total costs over 4 years | Accelerates translation of broadly applicable clinical platforms that address multiple PRMRP topic areas. | Pre-Proposal: July 23, 2026 Application: Sept. 22, 2026 |
Toxic Exposures Research Program (TERP)
| Mechanism | Who Should Apply | Funding | Purpose | Deadline |
|---|---|---|---|---|
| Clinical Trial Award (CTA) | Investigators with a clinical intervention ready for evaluation in human subjects, including multidisciplinary clinical research teams | Up to $4.5M total costs over 4 years | Supports Phase I–III clinical trials evaluating interventions for the prevention, diagnosis, treatment, or management of diseases and conditions associated with military-related toxic exposures. | Pre-Application: Aug. 19, 2026 Application: Nov. 19, 2026 |
| Investigator-Initiated Research Award (IIRA) | Independent investigators conducting basic, translational, preclinical, clinical, epidemiological, or population-based research | Up to $800,000 total costs over 3 years | Supports hypothesis-driven research that advances understanding, prevention, diagnosis, or treatment of diseases associated with military-related toxic exposures. Projects may range from basic laboratory studies through translational and clinical research (excluding clinical trials). (Memorial University Research Tools) | Pre-Application: Aug. 19, 2026 Application: Nov. 19, 2026 |
| Translational Research Award (TRA) | Investigators or multidisciplinary teams with promising discoveries ready for translational development; clinician–scientist partnerships are encouraged | Up to $1.5M total costs over 3 years | Accelerates translation of laboratory discoveries into clinical applications, including diagnostics, therapeutics, medical devices, biomarkers, and clinical practice guidelines. Includes an optional Partnering Principal Investigator Option (PPIO) to foster interdisciplinary collaborations. (Simpler Grants) | Pre-Application: Aug. 19, 2026 Application: Nov. 19, 2026 |
Vision Research Program (VRP)
| Mechanism | Who Should Apply | Funding | Purpose | Deadline |
|---|---|---|---|---|
| Clinical Trial Award (CTA) | Investigators or multidisciplinary teams with a clinical intervention ready for evaluation in human subjects | Up to $2.6M total costs over 3 years | Supports Phase I–III clinical trials evaluating promising interventions for vision injury or vision disorders relevant to military populations. | Pre-Application: July 28, 2026 Application: Nov. 12, 2026 |
| Investigator-Initiated Research Award (IIRA) | Independent investigators conducting basic, translational, preclinical, clinical, or epidemiological vision research | Up to $1.2M total costs over 3 years | Supports hypothesis-driven research that advances understanding, prevention, diagnosis, or treatment of vision injuries and diseases. Clinical trials are not supported under this mechanism. | Pre-Application: July 28, 2026 Application: Nov. 12, 2026 |
| Mentored Clinical Research Award (MCRA) | Early-career clinicians (e.g., MD, OD, DO, or equivalent) committed to developing independent careers in vision research under the guidance of an experienced mentor | Up to $75,000 total costs over 1.5 years | Provides protected research time and mentored training to develop the next generation of clinician-scientists in vision research. | Letter of Intent: Aug. 25, 2026 Application: Sept. 10, 2026 |
| Translational Research Award (TRA) | Investigators or multidisciplinary teams with promising laboratory discoveries ready for translational development; clinician–scientist collaborations are encouraged | Up to $1.6M total costs over 3 years | Accelerates translation of laboratory discoveries into clinically applicable diagnostics, therapeutics, medical devices, biomarkers, or other technologies that improve visual outcomes. | Pre-Application: July 28, 2026 Application: Nov. 12, 2026 |